Realtime verification of chemotherapy effectiveness project awarded $100k grant for commercialization

Boston University’s BOTLab receives $100,000 in endeavor to turn science into commercialized product from American Cancer Society and Global Center for Medical Innovation. Fulfilling its recent commitment to identify, develop, and promote technology innovation within the ACS portfolio of funded research, the American Cancer Society (ACS) and Global Center for Medical Innovation (GCMI) teams have…

Connect with GCMI at SPU 2018 to Learn How We Can Take Your Idea for an Innovative Urological Device from Concept to Commercialization

The Societies for Pediatric Urology (SPU) is a non-profit society whose main purpose is to promote pediatric urology, appropriate practice, education, and exchanges between practitioners. Every year, they host a Fall Congress that brings together practitioners and industry leaders to discuss the latest news and innovations in pediatric urology. This year, SPU’s Fall Congress will…

GCMI CEO Tiffany Wilson to present at U.S. Food & Drug Administration Public Meeting on Pediatric Medical Device Development

On August 14, 2018, GCMI CEO Tiffany Wilson will present before an open public meeting hosted by the U.S. FDA on Pediatric Medical Device Development in Silver Spring, MD. This meeting provides a discussion about strategies to enhance the medical device ecosystem to cultivate development and innovation of devices that serve the unique needs of…

Evaluating or Ready to Engage an Industry Leading Preclinical CRO? Connect with T3 Labs at TCT 2018, Booth 334!

The Transcatheter Cardiovascular Therapeutics (TCT) meeting is the world’s largest educational meeting specializing in interventional cardiovascular medicine. This year, it will take place on September 21-25, 2018 in San Diego, California. GCMI and T3 Labs will be attending as an exhibitor at TCT again this year. Our booth number is 334.  We’re excited to spend…

Insights from the SEMDA 2018 Marketing & Regulatory Session featuring GCMI’s Mike Fisher

The Marketing & Regulatory Session at SEMDA 2018 explored the goals, responsibilities, and possible pathways of medtech marketers when building awareness and adoption for their products. This session featured panelists Mike Fisher, Director of Product Development for GCMI; Allyson Bower-Willner, Senior Marketing Manager for Molnlycke; and Machelle Shields, Senior Executive Healthcare Policy & Compliance Advisor…